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Abstract
Background: Maternal and neonatal morbidity and mortality in Low Income Countries, especially in sub-Saharan
Africa involves numerous interrelated causes. The three-delay model/framework was advanced to better understand
the causes and associated
Contextual factors. It continues to inform many aspects of programming and research on combating maternal and
child morbidity and mortality in the said countries. Although this model addresses some of the core areas that can
be targeted to drastically reduce maternal and neonatal morbidity and mortality, it potentially omits other critical
facets especially around primary prevention, and pre- and post-hospitalization continuum of care.
Discussion: The final causes of Maternal and Neonatal mortality and morbidity maybe limited to a few themes
largely centering on infections, preterm births, and pregnancy and childbirth related complications. However, to
effectively tackle these causes of morbidity and mortality, a broad based approach is required. Some of the core
issues that need to be addressed include:-i) prevention of vertically transmitted infections, intra-partum related
adverse events and broad primary prevention strategies, ii) overall health care seeking behavior and delays therein,
iii) quality of care at point of service delivery, and iv) post-insult treatment follow up and rehabilitation. In this article
we propose a five-pronged framework that takes all the above into consideration. This frameworks further builds on
the three-delay model and offers a more comprehensive approach to understanding and preventing maternal and
neonatal morbidity and mortality in Low Income Countries
Conclusion: In shaping the post 2015 agenda, the scope of engagement in maternal and newborn health need to
be widened if further gains are to be realized and sustained. Our proposed five pronged approach incorporates the
need for continued investment in tackling the recognized three delays, but broadens this to also address earlier
aspects of primary prevention, and the need for tertiary prevention through ongoing follow up and rehabilitation. It
takes into perspective the spectrum of new evidence and how it can be used to deepen overall understanding of
prevention strategies for maternal and neonatal morbidity and mortality in LICS.
Keywords: Five pronged framework, Three delay Model, Maternal, Neonatal, Morbidity, Mortality, Low Income
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Background
In the last decade concerted efforts in low income coun-
tries (LICS) have led to a decline in the overall mortality
of children under the age of five years [1]. Sustaining
immunization programs and even introducing new vac-
cines for invasive bacterial diseases (haemophilus and
pneumococcal infections), and combating the burden of
falciparum malaria are some of the notable strategies
that have received consistent global funding and atten-
tion especially in sub-Saharan Africa [2, 3]. It is however
worth noting that most of the considerable decline in
morbidity and mortality has occurred in children, post
the neonatal and young infant age group (>2 months of
age) [2, 3]. Comparatively, neonatal mortality has shown
modest reduction [4, 5]. Furthermore, evidence shows
that neonatal deaths as proportion of total under-five
mortality has risen over the same time [6]. This may
suggest that our generic approach to combating under-
five mortality has not invested and deployed strategies
that specifically address the underlying causes of neo-
natal morbidity and mortality in LICS.
Improving maternal health is a key global agenda [7].
Although some progress has been noted, the goal of re-
ducing maternal mortality ratio (MMR) by three quar-
ters by 2015 remains unmet by most of the LICS [8]. In
most of the sub Saharan African region, MMR remains in
the very high category (510/100,000 live births), more than
double the global average of 210/100,000 [9]. Moreover,
the lifetime risk of maternal death in the LICS especially
sub Saharan Africa remains as high as 1 in 160 compared
to 1 in 3700 for developed countries [8]. In a nutshell, Ma-
ternal and Neonatal morbidity and mortality significantly
contribute to the overall global morbidity and mortality.
Most of this morbidity and mortality will continue to
occur in LICS such as the sub-Saharan African region. It
is therefore clear that with the dawn of the post 2015 era,
the question ‘where is the M in MCH?’ continues to be
highly valid thirty years after it was first asked [10]. How-
ever, the more ‘wholesome’ question to consistently ask in
every programmatic or research investment to combat
maternal and child mortality beyond 2015 may be where
is the ‘M & N’ in MNCH?
Maternal and neonatal morbidity and mortality in
LICS especially in sub-Saharan Africa involve numerous
interrelated causes [11]. The three-delay model/frame-
work was advanced to better understand the causes and
associated contextual factors [12]. The model comprises
delay in deciding to seek care (delay 1), delay in reaching
the health facility (delay 2), and delay in receiving quality
care once at the health facility (delay 3) [12]. Since its
advancement two decades ago, the three delay model/
framework has remained relatively unchanged [12]. It
continues to inform many aspects of programming and
research on combating maternal and child morbidity
and mortality in LICS. Although this model addresses
some of the main areas that can be targeted to drastically
reduce maternal and neonatal morbidity and mortality, it
potentially omits other critical facets especially around
primary prevention, and pre- and post-hospitalization con-
tinuum of care.
The post 2015 global deliberation needs to concisely
articulate where to invest in order to rapidly accelerate
the gains made in a push towards achieving the millen-
nium development goals (MDGs), particularly 4 & 5. In
doing so, several issues need to be taken into consider-
ation. First, LICS have witnessed reasonable economic
growth during the last two decades with many poised to
acquire middle or ‘near’ middle income status [13]. This
may result in meaningful national and regional funding
being available for maternal and child health programs
to complement global investments. Second, many of
these countries have also witnessed rapid urbanization
which may also require a rethink in public health ap-
proaches [13]. Third, the unprecedented knowledge
from more than two decades of public health program-
ming and research centered mainly on the three delay
model now exists. Finally, the epidemiological mix of the
major causes of maternal and newborn mortality may
have changed since the three-delay model was advanced
[14–17]. For example, HIV and AIDS may now be re-
sponsible for a sizeable proportion of maternal morbid-
ity and mortality in some countries [9]. Similarly, Group
B streptococcus contribution to neonatal sepsis in LICS
was still largely undocumented two decades ago but now
may be responsible for a fair proportion of sepsis-related
neonatal deaths in LICS [14–17]. Given all the above,
there is need to update the three-delay model to accur-
ately shape the post 2015 global health agenda . In this
article we draw on our own research in LICS and an un-
derstanding of the wider research literature to propose a
more comprehensive five-pronged framework (Table 1).
This framework, building on the three-delay model, is
discussed below.
Discussion
The final causes of Maternal and Neonatal mortality and
morbidity maybe limited to a few themes largely center-
ing on infections, preterm births, and pregnancy and
childbirth related complications. However, to effectively
address the same, a broad based approach is required.
Some of the core issues that need to be addressed in-
clude:-i) prevention of vertically transmitted infections,
intra-partum related adverse events and broad primary
prevention strategies, ii) overall health care seeking be-
havior and delays therein, iii) quality of care at point of
service delivery, and iv) post insult follow up and
rehabilitation.
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Table 1 Five-pronged framework for understanding and preventing Maternal-Neonatal morbidity and mortality in low income countries
Foetal-Maternal strategies Original component of the three-delay model advanced in 1994 Post-discharge follow up and
rehabilitation
(Primary Prevention) (Secondary Prevention) (Tertiary Prevention)
Prong 1 Prong 2 Prong 3 Prong 4 Prong 5
• Prevention of vertical transmission of
infections• Prediction and Preventing
intra-partum related neonatal morbidity
and mortality• Vaccines against causes
of early neonatal sepsis especially
Group BStreptococcus and other dis-
eases including HIV|AIDS• Chemo-
prophylaxis against GBS• Effective
prevention of mother to child
transmission of congenital infections
including HIV|AIDS• Barrier preventions
e.g provisions of LLITNSa• Family
planning, education and economic
empowerment of women• Specific
focus on adolescent girls
❖ Addressing delays in decision to seek
care• Education on danger signs
during pregnancy and early neonatal
life• Community engagement through
behavioral change and
communication strategies• Demand of
care creation
❖ Addressing delays in reaching point
of care once decision is made• financial
incentives e.g. transport refunds•
facility output-based financing ap-
proaches• referral systems that can
help minimize delays that contribute
to HIEb• use of community cadres
❖ Addressing delays in provision of
quality services at point of care• point
of care quality improvement
approaches• continuous investment in
in-service skills development•
operational research on how to best
offer care at point of service delivery•
More research on the role of facility
improvement teams• Continuous
direct investments in health systems
building blocks• Exploring adjunct
treatment options for infections and
HIE
❖ Post-discharge follow up and
rehabilitation• expanding of human
resource for health cadres with
rehabilitation skills (occupational,
physiotherapy,& psyscho-social sup-
port) in LICS• surveillance systems for
post-discharge complications and or
sequelea• specific follow up and treat-
ment of obstetrics complications
including obstetric fistulas• Ongoing
support where long-term impairments
are anticipated















We explore each of this facets below as the core com-
ponents of our proposed five pronged approach.
Prong 1: Foeto-Maternal strategies (including prevention
of vertical transmission of infections & intra-partum
related morbidity and mortality) coupled with broad
primary prevention strategies
The foeto-maternal interface represents a common route
of transmission of several infections including HIV and
AIDS, bacterial and even parasitic infections including
congenital malaria [9, 14, 15]. As already described, dis-
eases and conditions around the foeto-maternal interface
are now recognized as some of the main causes of ma-
ternal and neonatal morbidity and mortality. Of note,
Group B Streptococcus (GBS) continue to gain promin-
ence as a major cause of especially early onset neonatal
sepsis in LICS [14–19]. Therefore, strategies aimed at
addressing this first prong, such as chemo-prophylaxis
against bacterial and viral infections e.g Group B
Streptococcus, HIV and AIDS, and barrier protections
through long lasting insecticide treated mosquito nets
(LLITNs), offer an opportunity to reduce the burden of
maternal and neonatal morbidity and mortality in LICS
that need to be continuously supported in LICS. Import-
antly, approaches to specifically screen for and minimize
risk of GBS colonization among pregnant women have
shown promising results in reducing early onset sepsis
in high income countries [20–22]. Given the grown evi-
dence that GBS is equally significant in LICS there is a
need to explore how similar strategies can be rolled out
in low income regions. However, it is clear that In spite
of the opportunities that portend from the above out-
lined strategies, operational challenges may hinder their
largescale application in LICS. Given this, there is need
to continue research investments for viable vaccine op-
tions for conditions such as early neonatal sepsis due to
group B Streptococci and HIV|AIDS [15].
Apart from neonatal sepsis and vertical transmissions
of infections, intra-partum related neonatal morbidity
and mortality is a major contributor to neonatal morbid-
ity and mortality [4, 6, 23, 24]. Furthermore, intra-
partum related morbidity and mortality may be increas-
ing while that from sepsis is on the decline [6]. Available
literature suggests that interventions against intra-
partum related neonatal morbidity and mortality in LICS
are largely limited to promoting early access (prong 2 &
3) as advocated for in the three delay model, with hardly
any direct primary prevention strategies (prong 1), and
limited institutionalization of prongs 4 & 5 in respective
health care systems as outlined in our proposed frame-
work. Largely, viable evidence based direct primary pre-
vention (prong 1) interventions for perinatal asphyxia
including accurate prediction are yet to be fully devel-
oped [25–27]. Given this, emphasis must continue to be
put into facilitating early access and improving quality of
care during labor and delivery. However, there is need to
start exploring modalities of rolling out new treatment
options that have been shown to reduce long-term
neuro sequelea such as therapeutic hypothermia in LICS
[28, 29].
It is worth noting that for greater success to be
achieved, prong one interventions should also include
other broad strategies. Critical areas worth focusing on
include family planning, economic and education em-
powerment of women and girls, and a sustained strategy
to address the needs of adolescent girls [30, 31]. By pre-
venting unwanted pregnancies, and offering women op-
portunities to plan their reproductive choices, evidence
suggests that family planning is an effective and low cost
approach that may synergistically impact positively on
the other available repertoire of strategies to prevent ma-
ternal and newborn morbidity and mortality [32]. Recent
estimates indicate that family planning may indirectly
prevent up to a third of all maternal deaths and an even
higher number of neonatal and early childhood deaths
[31, 32]. Therefore rapidly scaling up access to, and
expanding family planning choices in sub Saharan Africa
and other LICS where the current coverage is under fifty
percent, should be a core priority in every global, re-
gional and country specific strategic plan that aims to
reduce maternal and neonatal deaths [30].
There are nearly 1.5 billion youths in the world today
[33]. More than half of them are girls and young women
with over 600 million adolescent girls living in low and
middle income countries (LMIC) of south east Asia and
sub-Saharan Africa [33]. These girls face many challenges
ranging from early marriages, lack of general education in-
cluding sex education, female genital mutilation, gender-
based-violence, and poor access to reproductive health
services especially family planning services [33]. It is esti-
mated that over 10 % of girls in regions such as the Sub
Saharan Africa may have their first child before the age of
16 years [34]. Overall, approximately 16 million births and
up to three million unsafe abortions occur among adoles-
cent girls [33, 34]. It is therefore not surprising that preg-
nancy complications are among the leading causes of
death among adolescent girls. Furthermore, still births
and newborn deaths may be much higher among adoles-
cent mothers [35]. It is notable that over the last decade,
MDGs barely focused on the plight of the adolescent girl.
Given the pivotal role of addressing issues affecting ado-
lescent girls as a strategy to improve overall maternal and
newborn health, the post 2015 global agenda should invest
heavily in this issue as part of the central global MNCH
agenda.
In summary, the three-delay model did not encompass
the importance of the foeto-maternal interface and its
role in combating neonatal morbidity and mortality. In
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its first ‘delay’, it largely fast-forwards to addressing indi-
vidual/family/societal/cultural elements [12]. It is how-
ever evident that considerable gains in reducing maternal
and neonatal morbidity and mortality in LICS may be
accrued from consistent investments in prong 1 as articu-
lated in our framework. Investments in prong 1 need to
especially bridge funding gaps in research on vertical
transmission of infections and intra-partum related mor-
bidity and mortality. In addition, investments in prong 1
should also focus on broad multi-systems and multi-
dimensional elements that can hardly be pinned to indi-
vidual choice/decision to-seek or not-to-seek healthcare
services that have traditionally been the focus of the first
delay in the three delay model.
Prong 2 and 3: Addressing delays in decision to seek care
and delays in reaching point of care once decision is
made (Health promotion during pregnancy)
Prongs two and three of our framework solidifies the
continued relevance of all the core aspects of the three-
delay model even in the post 2015 global health agenda.
Since the development of the three-delay model two de-
cades ago, concerted efforts have been made to under-
stand and address the first two components i.e. delay in
making a decision to seek care and delay in reaching a
health facility [36]. Ministries of Health in LICS, with
considerable support from bilateral funded health pro-
grams, have put substantial resources in campaigns to
enlighten their populace on most topical issues that
centre on eliminating the first delay. These include en-
couraging focused antenatal care, teaching pregnant
women on danger signs during pregnancy and the im-
mediate puerperium including signs of ill health among
newborns, and encouraging health facility delivery [36].
Further strategies including establishing more health fa-
cilities, having waiting homes near health facilities for
pregnant mothers, increasing the number of health
workers, and cash incentives to both the pregnant
women and health facilities continue to be rolled out in
LICS in a bid to further minimize the first and second
delays [37]. These strategies seem to have been justified
given that most deaths occurred, and continue to occur,
in remote rural homes [38]. Importantly, these efforts
may be bearing fruits [2, 5, 6].
Further research is needed, especially on innovative
approaches that create demand for health services and
encourage the use of community cadres for rapid assess-
ment and referral of pregnant women and newborn
babies requiring medical attention. Overall, global and
in-country investments in LICS towards eliminating
these first two central components of the three-delay
model need to continue beyond 2015 so that the gains
made over the last two decades can be sustained.
Prong 4: Addressing delays in provision of quality
services at the point of care
The third delay represents the most complex aspect of
the health care system i.e. the interaction between the
healthcare provider and the client. For quality care to
occur several requirements must be fulfilled during each
interaction. First, a healthcare worker needs to be avail-
able. Second, the healthcare worker needs to have the
necessary knowledge and skills to diagnose and treat the
presenting illness. Third, he or she requires appropriate
resources at hand to attend to the situation. Fourth, the
healthcare worker need to have put in place an efficient
facility ‘Micro-systems’ that ensure each client receives
the right care, consistently. Finally, they need to possess
the right behavioral attributes to offer the said care in an
empathetic and culturally appropriate manner. It is also
important to note that the clients’ perceptions of ‘poor’
quality of care may not reflect the true quality of care at
the point of service. Nevertheless, these are important
perceptions and need to be addressed.
Quality of care however cannot be comprehensively
addressed from only a narrow focus on individual
healthcare workers and their interaction with clients, but
must go deeper to consider the systems issues under-
lying those interactions. From the onset, improving qual-
ity of care in LICS requires broad-based investments in,
and monitoring of recognized building blocks for health,
and overall health systems strengthening [39]. Global
healthcare funding in the last several decades, though
laudable, remains predominantly biased towards disease-
specific responses rather than health systems responses
[40]. Although disease-specific investments may in some
instances lead to rapid initial results, institutionalization
and sustainability becomes problematic in a weak health
system milieu [40]. How to reallocate some existing glo-
bal as well as in-country funding in LICS to support
both disease-specific responses as well as broad health
systems responses will be key in driving sustainable im-
provement in the sector. For starters, it can address
some of the quality parameters articulated in the three-
delay model including provision of essential supplies,
equipping facilities, and staffing among others [12].
However, given that ‘systems’ responses may take longer
before results can be realized, it is likely that many fund-
ing organizations may be tempted to ‘shy’ away from
health systems investments unless there is a sustained
global agenda on strengthening health systems in LICS.
Many a times it is easy to perceive quality of care from
the availability or non-availability of required inputs (staff,
supplies, equipment’s, among others). This is clearly a
health system issue as described above. However, another
core aspect of quality of care is what happens at care
micro-systems level [41]. Even in well-resourced nations
with adequately financed health systems, and where
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equipment, supplies and staffing are not major concerns,
many clients may not consistently receive optimal care
[42]. This disconnect is now recognized as the ‘know-do-
gap’ [43]. This aspect of quality improvement is more
about ‘organizing processes of care’ within health facilities,
and their catchment communities in order to optimize
delivery of care. Some of the promising concepts to ad-
dress these issues have been the deliberate application of
improvement principles/approaches in healthcare settings
[44]. At the time of advancement of the three-delay
model, these concepts about quality improvement were
largely untested in healthcare systems in LICS. Over the
last decade, knowledge around the application of improve-
ment approaches in healthcare has rapidly evolved. How-
ever, it is worth noting that most of the documented
results have come from single-site facilities. Second, most
of these have provided data on application of such princi-
ples to circumscribed services only (e.g increase facility
delivery, or scale up HIV testing) not integrated health
services that each facility in LICS needs to offer. Third,
knowledge of the application of the said principles from a
health systems strengthening perspective is very limited,
making scale-up problematic [44].
Application of ‘improvement science’ in the health
sector to drive ‘quality of care’ in LICS hardly featured
as a core strategy and deliverable in the global health
systems strengthening agenda during the time the three
delay model was been advanced. Over the last two de-
cades, although numerous demonstrations of how this
can lead to improvement in service delivery have showed
some success, evidence demonstrating large-scale appli-
cation that can lead to national and global level impact
is lacking as noted above [45–47]. Therefore, large scale
implementation research is required to generate such
knowledge. Such a research agenda should explore how
to operationalize vertical scale up of ‘improvement
science’ (methods for institutionalization at national and
sub-national level), as well as horizontal scale up involv-
ing application of ‘improvement science’ at actual facility
level (care micro-systems) to address quality gaps in in-
tegrated health services.
Largely, although the importance of ‘quality of care’
was recognized in the three-delay model, it has not elic-
ited robust global attention. Furthermore, although the
phrase ‘quality of care’ may feature in most health pro-
grams write up, very few articulate any strategy for
achieving this at global, national or even care micro-
systems (health facility) level [45–47]. It is likely that this
may largely reflect lack of knowledge and skills on how
to apply improvement methods to health care settings at
programming level. Overall it is clear that ‘quality of care’
is central to achieving any global health goals. As noted
above, it may therefore be necessary to invest in largescale
operational research on continuous improvement of
‘quality of care’ in LICS, as a strategy in the post 2015 glo-
bal health agenda and how it can be applied as a strategy
to accelerate the progress towards ending preventable ma-
ternal and neonatal deaths.
Prong 5: Post-discharge/hospitalization follow up and
rehabilitation
Improved access and initial care may reduce early neo-
natal mortality but leave a sizeable proportion of infants
who are more likely to succumb at a later stage [48]. It
is likely that rudimentary post-discharge follow up and
rehabilitation systems may contribute to a proportion of
the post-discharge morbidity thus significantly hamper-
ing the overall impact of any investments to reduce
maternal and more so neonatal mortality [48]. Of major
concern too is that a sizeable proportion of neonates ad-
mitted and treated for various insults may be left with
severe neuro-developmental impairments leading to se-
verely constrained quality of life and requiring frequent
re-admissions, further straining the meager health sys-
tems and family resources in LICS [48]. Evidence further
suggests neonatal and perinatal insults maybe a major
cause of behavioral and mental disorders among survi-
vors which further require long-term care [48]. Overall
without any focus on long-term rehabilitation and follow
up, many of these children maybe dying prematurely dur-
ing childhood, further impacting on the family and com-
munity, and adversely affecting overall life-expectancy and
disability-adjusted life-years in LICS [48–51].
Besides the high post discharge mortality and long
term neuro squeal from perinatal and neonatal insults,
many women suffer long term complication especially
during labor and delivery in low income countries such
as obstetric fistulas among others [52, 53]. Estimates
suggests that for every dead mother from pregnancy re-
lated complications in LICS, fifteen times more maybe
left with long term grievous morbidity [52]. Despite this,
programing based on the three delay model continue to
largely focus on access and initial treatment with little
systematic infrastructure for follow up and rehabilitation
of women with such debilitating morbidity, with recent
estimates indicating that nearly one million women are
living with untreated obstetric fistulas globally [54].
Overall, despite the evidence that there is need to
focus on post-discharge follow up, investments to pre-
vent maternal and newborn morbidity and mortality in
LICS have hardly focused on the post hospitalization
period and rehabilitation. The prime focus has been
skewed towards preventing ‘initial’ mortality. It is likely
that in such a healthcare system where effort is limited
to only preventing deaths at the initial client-facility con-
tact, immediate neonatal care and outcomes may im-
prove. However, this may be spurious, resulting from
simply shifting a large share of the mortality burden to
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the post-discharge period and further creating an epi-
demic of severe impairment in fragile healthcare systems
in LICS [48].
In summary, emerging evidence continues to suggest
that even after preventing ‘initial’ mortality, a consider-
able number of neonates and young infants die after dis-
charge from healthcare facilities in LICS [49]. Given that
global, regional and in-country public health invest-
ments have predominantly applied the three-delay
model in their programming, this aspect of the health-
care system in LICS is largely ignored. Consequently,
post-hospitalization follow up and rehabilitation infra-
structure (systems for follow up, human resource
trained on rehabilitation post-sequelae) is largely non-
existent [48]. Moving forward it is evident that continu-
ing to ignore the need to strengthen the post discharge
aspects of the healthcare systems in LICS will hamper
any set goals, especially on reducing maternal and neo-
natal morbidity and mortality and improving the overall
health and survival of children.
Conclusion
The three-delay model has positively influenced global
health-related development agenda, especially approaches
towards achieving the prescribed aspirations of the now
ending MDGs 4 & 5 over the last two decades. While it is
recognized that many LICS have fallen short of the set tar-
gets within the MDGs time frame, appreciable gains have
nevertheless been documented in reducing maternal and
neonatal mortality. However, it apparent that, in moving
to the post 2015 agenda, the scope of engagement in ma-
ternal and newborn health must be widened if these gains
are to be sustained.
The five pronged approach we propose incorporates
not only the need for continued investment in tackling
the recognized three delays, but broadens this to also
address earlier aspects of primary prevention, and the
need for tertiary prevention through ongoing follow up
and rehabilitation. Critically, it takes into perspective the
spectrum of new evidence and how it can be deployed
to deepen overall understanding of prevention strategies
for maternal and neonatal morbidity and mortality in
LICS. Certain aspects in all five prongs will require more
investments in research to advance our understanding of
fundamental aspects of maternal-neonatal morbidity and
mortality, for example primary prevention of intrauter-
ine hypoxemia and vaccine advances for diseases such as
group B Streptococcus and HIV and AIDs. However,
equally important is investment in the ‘science’ of how
to consistently deliver the multitudes of known high im-
pact interventions (health services research in LICS).
The five pronged framework provides a ‘crystalline lens’
that can be used to aid the crafting and implementation of
the post 2015 health-related development agenda especially
in combating maternal and neonatal morbidity and mortal-
ity in LICS, and builds on the pillars of the three-delay
model. The proposed framework brings public health
approaches to improving maternal and new-born health in
LICS closer to what is been practiced in the high middle,
and high income regions in line with current evidence.
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